M. Wickremasinghe

839 total citations
17 papers, 610 citations indexed

About

M. Wickremasinghe is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Infectious Diseases. According to data from OpenAlex, M. Wickremasinghe has authored 17 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Epidemiology and 6 papers in Infectious Diseases. Recurrent topics in M. Wickremasinghe's work include Tuberculosis Research and Epidemiology (6 papers), Mycobacterium research and diagnosis (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). M. Wickremasinghe is often cited by papers focused on Tuberculosis Research and Epidemiology (6 papers), Mycobacterium research and diagnosis (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). M. Wickremasinghe collaborates with scholars based in United Kingdom, United States and Australia. M. Wickremasinghe's co-authors include Athol U. Wells, Robert Wilson, Heinke Kunst, Damien Ming, Gregory J. Keir, Elisabetta Renzoni, Toby M. Maher, Andrew G. Nicholson, Angelo De Lauretis and David M. Hansell and has published in prestigious journals such as European Respiratory Journal, Thorax and Respirology.

In The Last Decade

M. Wickremasinghe

16 papers receiving 596 citations

Peers

M. Wickremasinghe
M. Wickremasinghe
Citations per year, relative to M. Wickremasinghe M. Wickremasinghe (= 1×) peers Hidekazu Matsushima

Countries citing papers authored by M. Wickremasinghe

Since Specialization
Citations

This map shows the geographic impact of M. Wickremasinghe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Wickremasinghe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Wickremasinghe more than expected).

Fields of papers citing papers by M. Wickremasinghe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Wickremasinghe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Wickremasinghe. The network helps show where M. Wickremasinghe may publish in the future.

Co-authorship network of co-authors of M. Wickremasinghe

This figure shows the co-authorship network connecting the top 25 collaborators of M. Wickremasinghe. A scholar is included among the top collaborators of M. Wickremasinghe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Wickremasinghe. M. Wickremasinghe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Russell, Anne‐Marie, M. Wickremasinghe, Raminder Aul, et al.. (2020). Measuring Patient Activation Measurement in Patients Diagnosed with Interstitial Lung Disease (ILD) to Inform Enabling and Compassionate Care. A4640–A4640. 1 indexed citations
3.
Stone, Bryan L., et al.. (2019). P173 The grenfell fire: experience of a community clinic. A184.1–A184. 1 indexed citations
4.
Wickremasinghe, M., Huzaifa Adamali, Sophie Fletcher, et al.. (2018). S77 The idiopathic pulmonary fibrosis patients reported outcome measure (IPF-PROM) is reliable and valid for use in populations with IPF. ePrints Soton (University of Southampton). A47–A47. 3 indexed citations
5.
Singanayagam, Aran, David Connell, James D. Chalmers, et al.. (2016). Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis. The International Journal of Tuberculosis and Lung Disease. 20(12). 1653–1660. 12 indexed citations
6.
Datta, Arnab, et al.. (2016). P276 Development of patient reported experience measure (PREM) for idiopathic pulmonary fibrosis (IPF). Thorax. 71(Suppl 3). A238.1–A238. 2 indexed citations
7.
Fisher, Murray, Toby M. Maher, M A Spiteri, et al.. (2014). M272 Estimated Cost And Payment By Results (pbr) Tariff Reimbursement For Idiopathic Pulmonary Fibrosis Services Across 14 Specialist Providers In England. Thorax. 69(Suppl 2). A222–A225. 1 indexed citations
8.
Wickremasinghe, M., Graham Cooke, Monica Rebec, et al.. (2013). P25 Sensitivity of the Xpert®MTB/RIF assay in bronchoalveolar lavage samples in a North West London Hospital: a useful adjunct to current diagnostic modalities. Thorax. 68(Suppl 3). A85.2–A85. 1 indexed citations
9.
Keir, Gregory J., Toby M. Maher, Damien Ming, et al.. (2013). Rituximab in severe, treatment‐refractory interstitial lung disease. Respirology. 19(3). 353–359. 191 indexed citations
10.
Navani, Neal, Philip L. Molyneaux, Ronan Breen, et al.. (2011). Utility of endobronchial ultrasound-guided transbronchial needle aspiration in patients with tuberculous intrathoracic lymphadenopathy: a multicentre study. Thorax. 66(10). 889–893. 140 indexed citations
12.
Bloch, Susannah, et al.. (2009). Paradoxical reactions in non-HIV tuberculosis presenting as endobronchial obstruction. European Respiratory Review. 18(114). 295–299. 22 indexed citations
13.
Wickremasinghe, M., et al.. (2009). Tuberculin Skin Testing Prior to Anti-TNFα Therapy and Treatment of Latent Tuberculosis Infection.. A5930–A5930. 1 indexed citations
14.
Kunst, Heinke, M. Wickremasinghe, Athol U. Wells, & Robert Wilson. (2006). Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis. European Respiratory Journal. 28(2). 352–357. 101 indexed citations
15.
Wickremasinghe, M.. (2005). Non-tuberculous mycobacteria in patients with bronchiectasis. Thorax. 60(12). 1045–1051. 123 indexed citations
16.
Wickremasinghe, M.. (1997). Respiratory conditions associated with haematological malignancies. Thorax. 52(4). 390–391. 2 indexed citations
17.
Myers, J. D., et al.. (1997). Attenuation of propranolol-induced bronchoconstriction by frusemide.. Thorax. 52(10). 861–865. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026